Company Profile
CEO
Mr. Robert M. Davis J.D.(Chairman, President & CEO)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73.0K
Beta
0.22
Forward P/E
12.6
52W High
$125.14
52W Low
$76.66
Profit Margin
13.6%
Operating Margin
38.6%
Return on Equity
18.9%
Revenue Growth
4.9%
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Ademp...
Valuation
Market Cap$295.00B
P/E (TTM)33.63
P/S (TTM)4.53
EV/EBITDA--
Cash Flow
FCF Yield+4.0%
SBC Adj. FCF Yield+3.7%
SBC Impact6.3%
Margins & Growth
Profit Margin-26.0%
Operating Margin--
Revenue YoY4.9%
Earnings YoY--
Balance
Cash$5.33B
Debt$46.67B
Net Cash$-41.35B
Dividend
Dividend Yield2.85%
Payout Ratio--
Quarterly Payout$2.10B